Form D · Biotechnology

Innomed Healthscience, Inc.

Deerfield Beach, FL · CIK 0001643031

Offering snapshot reported May 30, 2019 · SEC filing

Reported sold
Yet to sell
Indefinite offering
Investors reported
0
Form D · investor count
Minimum accepted
$30K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 30, 2019InitialYet to sellNo comparison0SEC filing
Jul 5, 2018Amendment$181,250No comparison8SEC filing
Jan 8, 2018InitialYet to sellNo comparison0SEC filing
Jun 2, 2015Amendment$383,250$0vs May 28, 20157SEC filing
May 28, 2015Initial$383,250No comparison7SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-340724
Max offering $5,000,000. Minimum purchase 20,000 units@$1.50 per unit (each unit consists of 1 share common stock plus 3 warrants, exercisable at $0.75 per warrant).

Source: Form D, filed May 30, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lewis Javier Collazo Director, Executive
Louis Javier Collazo Director, Executive
Shara Hernandez Director, Executive, Promoter
Ron F Richard Director, Executive
Ronald Fred Richard Director
Bruce Sher Director, Executive, Promoter
Robert Watson Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1701 West Hillsboro Boulevard Suites 303 305
Deerfield Beach, FL, 33442